Aging, Blood Pressure, Cognitive Decline, Physical Activity, Physical Disability, Sarcopenia
Conditions
Keywords
Older adults, Physical function, Muscle mass, Short-term memory, Executive function, Blood Pressure, Resistance training, Exercise training, Periodization
Brief summary
The present study aimed at investigating the effects of two different resistance training protocols - nonperiodized (NP) and daily undulating periodization (DUP) - on hemodynamic, morphofunctional and cognitive parameters of robust older women. Methods: Forty-two older women were randomized allocated into one of the three experimental groups: NP, DUP, and control group (CG). Evaluations of the hemodynamic, morphofunctional and cognitive parameters occurred before, during and after six months. The exercise groups performed the program of exercise twice a week over 22 weeks. In NP, the two weekly sessions were based on 3 sets of 8-10 repetitions at a difficult intensity. However, in DUP, a power exercise session based on 3 sets of 8-10 repetitions at a moderate intensity was added in the first session of the week.
Interventions
OTHERPhysical exercise
The interventions proposed in the present trial were based on a safe and well-established exercise training program
Sponsors
University of Campinas, Brazil
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
FEMALE
Age
60 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Aged ≥60 years; * Female; * Not having been part of a systematic program of physical exercises in the last 6 months; * MEEM score \>19 points; * Kihon checklist score \>10 points; * Capacity to perform the basic and instrumental activities of daily living according to Katz and Pfeffer indexes; * Self-reported good memory; * Complete all measurements.
Exclusion criteria
* Changes on antihypertensive medication in the past 6 months prior to inclusion in the study; * Cardiovascular disease (i.e., acute myocardial infarction, stroke, peripheral arterial disease, and transient ischemic disease) * Metabolic disease (i.e., diabetes mellitus type I or II), pulmonary disease (i.e., emphysema) * Neurological and/or psychiatric disease (i.e., Parkinson's or Alzheimer's disease) * Skeletal muscle disorders * Comorbidities associated with greater risk of falls * Recent history of smoking or alcohol abuse * Hormone replacement therapy and/or psychotropic drugs.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Changes in transfer capacity in seconds | 6 months | TUG performance |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Changes in fat-free mass in kg | 6 months | Fat-free mass |
| Changes in overall cognitive capacity in points | 6 months | MEEM |
| Changes in blood pressure in mmHg | 6 months | Blood Pressure |
| Changes in shor-term memory in points | 6 months | Memory |
Outcome results
None listed